跳到主要导航
跳到搜索
跳到主要内容
北京理工大学 首页
English
中文
首页
师资队伍
研究单位
科研成果
奖项
按专业知识、名称或附属进行搜索
查看 Scopus 资料
崔 晗
光电学院
h-index
204
引用
7
H-指数
根据储存在 Pure 的刊物以及来自 Scopus 的引用文献数量计算
2014
2024
每年的科研成果
概览
指纹图谱
合作网络
科研成果
(31)
相似学者
(4)
指纹图谱
深入其中 Han Cui 为活跃的研究主题。这些主题标签来自此人的成果。它们共同形成唯一的指纹。
分类
加权
按字母排序
Engineering
Axial Resolution
5%
Carbonate Content
14%
Chemical Information
7%
Component Analysis
14%
Confocal Imaging
9%
Confocal Microscope
16%
Confocal Microscopy
64%
Demonstrates
5%
Experimental Result
19%
Fitting Curve
14%
Image Analysis
7%
Image Restoration
21%
Imaging Systems
15%
Intensity Noise
14%
Laser System
7%
Lateral Resolution
18%
Light Source
14%
Material Composition
7%
Material Interface
28%
Maximum Likelihood
14%
Microelectromechanical System
28%
Microrobots
14%
Microstructure
13%
Nanometre
14%
Obtains
5%
Optical Axis
10%
Optical Fiber Coupling
35%
Optical Probe
7%
Optoelectronics
14%
Pretreatment
14%
Principal Components
14%
Pulse Duration
7%
Quadratic Curve
14%
Reflected Light
7%
Relay System
7%
Resolution Image
5%
Response Curve
8%
Restoration Algorithm
8%
Sample Surface
19%
Scan Speed
7%
Scanning Process
7%
Scattered Light
7%
Spatial Resolution
17%
Spectral Range
7%
Spectral Resolution
14%
Two Dimensional
14%
Physics
Brillouin Scattering
14%
Carbon Nanotube
14%
Curve Fitting
19%
Graphene
19%
High Resolution
7%
Image Restoration
9%
Label-Free
7%
Laser-Induced Breakdown Spectroscopy
14%
Light Source
14%
Luminous Intensity
28%
Measurement Method
14%
Microelectromechanical System
14%
Noise Intensity
14%
Numerical Aperture
28%
Raman Spectra
42%
Raman Spectroscopy
100%
Rangefinding
14%
Signal-to-Noise Ratio
7%
Silica
14%
Silicon Carbide
14%
Silicon Dioxide
14%
Systems Stability
14%
Time Measurement
19%
White Noise
14%
Medicine and Dentistry
Bone
42%
Brillouin Scattering
14%
Cancer Cell
14%
Cancer Tissue
7%
Carbonic Acid
19%
Combination Therapy
7%
Confocal Microscopy
23%
Malignant Neoplasm
14%
Maximum Likelihood Method
14%
Morphology
14%
Raman Microscopy
39%
Raman Scattering
14%
Raman Spectrometry
58%
Signal-to-Noise Ratio
7%
Stomach Cancer
7%
Therapeutic Procedure
7%
Volociximab
7%
